A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis
Condition:   Langerhans Cell HistiocytosisIntervention:   Drug: GSK2110183Sponsors:   Octagon Research Solutions, Inc.;   Octagon Research Solutions, Inc.Active, not recruiting - verified March 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 12, 2011 Category: Research Source Type: clinical trials

A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis
Condition:   Langerhans Cell HistiocytosisIntervention:   Drug: GSK2110183Sponsors:   Accenture;   AccentureActive, not recruiting - verified May 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 12, 2011 Category: Research Source Type: clinical trials

Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies
Conditions:   Acute Undifferentiated Leukemia;   Adult Acute Lymphoblastic Leukemia in Remission;   Adult Acute Myeloid Leukemia in Remission;   Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities;   Adult Acute Myeloid Leukemia With Del(5q);   Adult Acute Myeloid Leukemia With Inv(16)(p13;q22);   Adult Acute Myeloid Leukemia With t(15;17)(q22;q12);   Adult Acute Myeloid Leukemia With t(16;16)(p13;q22);   Adult Acute Myeloid Leukemia With t(8;21)(q22;q22);   Adult Grade III Lymphomatoid Granulomatosis;   Adult Langerhans Cell Histiocytosis;   Adult Nasal Type Extranodal NK/T...
Source: ClinicalTrials.gov - January 7, 2011 Category: Research Source Type: clinical trials

Prospective Evaluation of Adult Pulmonary Langerhans Cell Histiocytosis
Condition:   Adult Pulmonary Langerhans Cell HistiocytosisIntervention:   Behavioral: Tabacco discontinuationSponsor:   Assistance Publique - Hôpitaux de ParisCompleted - verified April 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2010 Category: Research Source Type: clinical trials